Skip to content
Screener

Odyssey Therapeutics ODTX EPS (Diluted)

EPS (Diluted) at other companies

Veradermics logo
VeradermicsMANE
-$1.32+93.3%
BK
BKBK
$2.24+41.8%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Schering-Plough logo
Schering-PloughSGP
-$0.69+82.6%
Dycom Industries logo
Dycom IndustriesDY
$3.00+43.5%
Target logo
TargetTGT
$1.71-24.7%

Other financials

Income statement

See full
Revenue--100%
Operating income-$55.5M-32.3%
Net income-$52.8M-28.0%

Balance sheet

See full
Cash & equivalents$82.0M-49.7%
Total debt$24.8M+8,175%
Total equity$421.2M+197%
Total assets$483.9M—

Cash flow

See full
Operating cash flow-$34.5M-0.7%
CapEx$186.0K+541%
Free cash flow-$34.7M-1.2%

Valuation

See full
Market cap$1B+27.8%
Enterprise value$946.17M—
P/S348.8×—

Profitability

See full
Operating margin-6,129%—
Net margin-5,934%—
FCF margin-5,203.9%—

Returns & leverage

See full
Return on equity-8,434.8%—
Debt / equity0.1×—
Current ratio11.4×—

Where this comes from

Reported directly by Odyssey Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335822

FAQ

What is Odyssey Therapeutics's EPS (diluted)?
Odyssey Therapeutics (ODTX) reported EPS (diluted) of -$1.74 in Q2 2026.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Odyssey Therapeutics's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude